new-pneumococcal-vaccine

Home » Pneumosil®, from Serum Institute of India achieves WHO prequalification » new-pneumococcal-vaccine

Downloads: full (2100x1500) | large (980x700) | medium (300x214) | thumbnail (150x150)

About Us

Fina Biosolutions, LLC was founded in 2006 by Dr. Andrew Lees with an initial focus on helping emerging market vaccine manufacturers learn to make affordable conjugate vaccines. FinaBio has since grown to offer a variety of bioconjugation and protein services. The company is located in the heart of Maryland’s biotechnology corridor.

Facebook
LinkedIn

Business Info

9430 Key West Ave., Suite 200
Rockville, MD 20850
877-346-2246 (877-FinaBio)
info@finabio.com

Quick Links

Fina Biosolutions: Conjugate Vaccines, Protein CRM197
About Us
Contact Us
Terms & Conditions of Sale
Privacy Policy

The Medicine Maker Power List hails one hundred of the best and brightest individuals involved in drug development.